Morgan Stanley Keeps Their Hold Rating on Medtronic (MDT)

By Austin Angelo

Morgan Stanley analyst David Lewis maintained a Hold rating on Medtronic (MDTResearch Report) today and set a price target of $105. The company’s shares closed last Monday at $102.15, close to its 52-week high of $103.95.

According to, Lewis is a 5-star analyst with an average return of 9.1% and a 71.1% success rate. Lewis covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and TransMedics Group Inc.

Currently, the analyst consensus on Medtronic is a Strong Buy with an average price target of $106.64.

See today’s analyst top recommended stocks >>

Medtronic’s market cap is currently $137.3B and has a P/E ratio of 29.94. The company has a Price to Book ratio of 2.74.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.